By Shalini Bhardwaj

New Delhi [India], August 26 (ANI): There is no proposal in consideration to change the dose interval between two COVID-19 vaccines--Covishield, Covaxin, and Sputnik V in India, National Technical Advisory Group on Immunisation's (NTAGI) chairman Dr Nk Arora said on Thursday.

Also Read | PM Narendra Modi To Dedicate Renovated Complex of Jallianwala Bagh Smarak to Nation on August 28.

Arora while speaking to ANI said, "There are several studies and programmatic data collection processes are on to assess the vaccine effectiveness. NTAGI is reviewing the vaccine effectiveness data on regular basis. Currently, there is no proposal for change in the interval of doses for COVISHIELD, COVAXIN, and SPUTNIK V under consideration."

Earlier there were reports that government could make a move to reduce the minimum gap between two doses of the Covishield COVID-19 vaccine, but NTAGI has denied the reports.

Also Read | Chennai Man Dupes People of Rs 1.5 Crore on Promise of Doubling Their Money in 100 Days, Arrested.

At present, Covishield is being administered in the country with the two doses having a gap of 12-16 weeks.

In the month of MAY this year, the gap was increased from 6-8 weeks to 12-16 weeks.When the nationwide vaccination has started in January this year, the Covishield dosage gap was set at 4-6 weeks. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)